Rodrigo Edelmuth

Jul 30, 2023 | survivornet.com | Rodrigo Edelmuth

A combination of multiple therapies, including an immunotherapy (Infinzi), a PARP inhibitor (Lynparza), and chemotherapy showed promise in treating some patients with advanced endometrial cancer. Endometrial cancer starts in the inner lining of the uterus, called the endometrium. Previously, there had not been many good treatment options for women with advanced disease.

Jul 23, 2023 | survivornet.com | Rodrigo Edelmuth

It is common for patients with advanced cancer to experience a loss of appetite, which may be attributed to the cancer itself. An old and low-cost drug called olanzapine can improve appetite and weight gain among newly diagnosed patients with advanced lung and upper gastrointestinal cancer starting chemotherapy. Short-duration (1-4 days) (doses of 5 or 10 mg per day) has become popular in oncology as a safe, effective, and inexpensive appetite stimulant.

Jul 23, 2023 | survivornet.com | Rodrigo Edelmuth

New Approach To Appetite Stimulation For Cancer PatientsIt is common for patients with advanced cancer to experience a loss of appetite, which may be attributed to the cancer itself. An old and low-cost drug called olanzapine can improve appetite and weight gain among newly diagnosed patients with advanced lung and upper gastrointestinal cancer starting chemotherapy.

Jul 8, 2023 | survivornet.com | Rodrigo Edelmuth |Nina Shah |Elizabeth Comen |Brian Berman

Can Antibiotics Increase the Chances of Cancer Coming Back? A recent study by researchers at Stanford Medicine says that the use of multiple antibiotics may be associated with a specific type of breast cancer, triple negative breast cancer, returning after treatment (recurrence). Researchers demonstrated that a correlation between antibiotic use and breast cancer recurrence might exist, but they cannot definitively say that antibiotics cause recurrence at this time.

Apr 3, 2023 | survivornet.com | Rodrigo Edelmuth

Protecting the Hearts of Children With CancerSome chemotherapy drugs can be toxic to patients’ heart function, especially for children. Doxorubicin is an important and highly effective drug in the treatment of some common types of childhood and adult cancers, such as acute lymphoblastic leukemia or Hodgkin lymphoma. Unfortunately, doxorubicin can lead to heart damage.